Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Newborn T cells found to excel in immune defense

Scientists have long believed that a newborn's immune system was an immature version of an adult's, but new research from Cornell University shows that newborns' T cells – white blood cells that protect from disease – outperform those of adults at fighting off numerous infections.

24 Feb 2024

Digital DNA melting analysis can be a faster and more reliable tool for pathogen detection

A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis.

21 Feb 2024

NIH grant boosts research on biofilm dispersal in wound infections

Most chronic wound infections share one thing in common: the presence of biofilms, which are composed of many different microorganisms that congregate as a mass, usually on some type of surface such as a wound bed.

21 Feb 2024

Understanding the impact of spring allergies on different body systems

If you suffer from spring allergies, you already know you tend to feel miserable once pollen season descends.

19 Feb 2024

FDA approves omalizumab for food allergy reactions based on NIH research

Today's Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins the FDA decision.

16 Feb 2024

The role of odor and verbal cues in recalling memories

Whether odor vs word cues could prompt memory in MDD patients with deficits in specific AM recall.

16 Feb 2024

Maternal mRNA COVID-19 vaccination shields infants for six months

Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

15 Feb 2024

Le Bonheur's risk-based innovation program reduces health care use related to asthma

Le Bonheur's risk-based innovation program Changing High-Risk Asthma in Memphis through Partnership (CHAMP) significantly decreased health care use related to asthma by targeting barriers to asthma care, according to research published in the Annals of Allergy, Asthma & Immunology.

14 Feb 2024

Promising new CMV vaccine shows stronger immune response

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according to a study by Weill Cornell Medicine investigators.

12 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024

Study finds gender disparity in quality of life for individuals with food allergies

Researchers examined the correlation between health-related quality of life (HRQL) and biological sex among individuals with immunoglobulin E (IgE)-related food allergies and their care providers.

9 Feb 2024

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).

9 Feb 2024

Experimental mRNA vaccine against CMV elicits promising immune responses

7 Feb 2024

Promising influenza drug candidate shows activity against resistant variants

Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral Research at Georgia State University.

6 Feb 2024

Allergy News and Research

Further Reading

Newborn T cells found to excel in immune defense

Digital DNA melting analysis can be a faster and more reliable tool for pathogen detection

NIH grant boosts research on biofilm dispersal in wound infections

Understanding the impact of spring allergies on different body systems

FDA approves omalizumab for food allergy reactions based on NIH research

The role of odor and verbal cues in recalling memories

Maternal mRNA COVID-19 vaccination shields infants for six months

Le Bonheur's risk-based innovation program reduces health care use related to asthma

Promising new CMV vaccine shows stronger immune response

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Study finds gender disparity in quality of life for individuals with food allergies

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

Experimental mRNA vaccine against CMV elicits promising immune responses

Promising influenza drug candidate shows activity against resistant variants

Clinique and Mount Sinai partner to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

Congressman off-base in ad claiming Fauci shipped covid to Montana before the pandemic

New study reveals cefoxitin as effective first-line treatment for intraamniotic infections

Study shows how low dose of cadmium produces deleterious stress in lung epithelial cells

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

New insights on how diet regulates allergic responses

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News